White House says it’s considering intellectual property waiver for COVID-19 vaccines

Published: Updated:

The White House is considering options for maximizing production and supply of COVID-19 vaccines for the world at the lowest cost, including backing a proposed waiver of intellectual property rights, but no decision has been made, press secretary Jen Psaki said on Tuesday.

For more coronavirus news, visit our dedicated page.

“There are a lot of different ways to do that. Right now, that’s one of the ways, but we have to assess what makes the most sense,” Psaki said, adding that US officials were also looking at whether it would be more effective to boost manufacturing in the US.

Read more:

Heathrow Airport raises fees to help recover COVID-19 losses

Biden says talks ongoing about US shipments of COVID-19 vaccine abroad

Portugal’s COVID-19 state of emergency to end Friday